Stockholders' Equity | Note 5. Stockholders' Equity Dividends On January 16, 2025, our board of directors declared a quarterly dividend of $0.43 per share of common stock to be paid in cash on February 28, 2025 to shareholders of record at the close of business on January 31, 2025. In 2024, we paid aggregate annual cash dividends per share of $1.56. We paid aggregate annual cash dividends per share of $1.78 and $1.24 in 2023 and 2022, respectively. In 2023, this included a special dividend of $0.38 per share paid in the fourth quarter. Stock Options Effective January 2, 2025, the compensation committee of our board of directors granted to our employees options to purchase a total of 639,304 shares of our common stock at an exercise price of $72.00 per share. On the same date, certain of our non-employee directors received options to acquire a total of 44,014 shares of our common stock at an exercise price of $72.00 per share. The closing stock price on the effective date of the grants was $71.11 per share. The following tables summarize the details of options granted under our stock option plans that were still outstanding as of December 31, 2024, and the assumptions used to value those grants. All such grants were effective at the close of business on the date of grant. Options Option Exercise Closing Stock December 31, 2024 Date of Grant Options Options January 2, 2024 814,912 $ 64.00 $ 63.550 766,463 47,567 January 3, 2023 1,071,943 $ 48.00 $ 47.400 883,852 180,820 January 3, 2022 713,438 $ 62.00 $ 61.980 529,511 197,013 January 4, 2021 741,510 $ 48.00 $ 47.650 477,333 223,592 January 2, 2020 902,263 $ 38.00 $ 37.230 514,889 313,822 January 2, 2019 1,316,924 $ 26.00 $ 25.705 532,075 404,203 January 2, 2018 1,087,936 $ 27.50 $ 27.270 318,598 248,436 January 3, 2017 1,529,578 $ 23.50 $ 23.475 158,168 117,840 April 19, 2016 1,690,880 $ 23.00 $ 22.870 47,038 47,038 Total 9,869,384 4,227,927 1,780,331 Date of Grant Risk-free Expected Life Expected Expected Estimated Fair January 2, 2024 3.8% 5.00 2.2% 28.44 % $ 15.87 January 3, 2023 4.0% 5.00 2.6% 29.58 % $ 11.62 January 3, 2022 1.3% 5.00 1.7% 28.52 % $ 13.68 January 4, 2021 0.4% 5.00 2.0% 29.17 % $ 9.57 January 2, 2020 1.7% 5.00 2.4% 25.70 % $ 6.81 January 2, 2019 2.5% 5.00 2.9% 23.96 % $ 4.40 January 2, 2018 2.2% 5.00 2.3% 23.45 % $ 5.02 January 3, 2017 1.9% 5.00 2.6% 24.49 % $ 4.20 April 19, 2016 1.3% 5.00 2.6% 26.34 % $ 4.09 All of the options in the tables above vest and become exercisable over a period of up to eight years. Generally, each option will terminate approximat ely 10 years after the grant date. The fair value of each share-based option is estimated on the date of grant using a Black-Scholes valuation method that uses the assumptions listed above. The risk-free interest rate is based on the U.S. Treasury rate over the expected life of the option at the time of grant. The expected life is the average length of time over which we expect the employee groups will exercise their options, net of forfeitures, which is based on historical experience with similar grants. The dividend yield is estimated over the expected life of the option based on our current dividend payout, historical dividends paid, and expected future cash dividends. Expected stock volatilities are based on the movement of our stock price over the most recent historical period equivalent to the expected life of the option. A summary of activities under our stock option plans consisted of the following: Options Exercise Price (1) Remaining Life (2) Outstanding as of January 1, 2024 4,974,078 $ 38.70 5.99 Granted 814,912 $ 64.00 9.00 Exercised (1,338,085) $ 29.72 Cancelled/forfeited (222,978) $ 48.12 Outstanding as of December 31, 2024 4,227,927 $ 45.93 6.28 Exercisable as of December 31, 2024 1,780,331 $ 38.08 4.94 Options Exercise (1) Remaining Life (2) Outstanding as of January 1, 2023 5,374,736 $ 34.37 5.66 Granted 1,071,943 $ 48.00 9.00 Exercised (1,170,693) $ 25.69 Cancelled/forfeited (301,908) $ 45.00 Outstanding as of December 31, 2023 4,974,078 $ 38.70 5.99 Exercisable as of December 31, 2023 2,197,022 $ 30.88 4.54 (1) Weighted average exercise price. (2) Weighted average remaining contractual life in years. The total intrinsic value of stock options exercised during the years ended December 31, 2024, 2023, and 2022 was $57.6, $38.1, and $10.2, respectively. The intrinsic value represents the difference between the exercise price and fair value of the underlying shares at the date of exercise. At December 31, 2024, there was $19.0 of total unrecognized stock-based compensation expense related to outstanding unvested stock options granted under the employee stock option plan. This expense is expected to be recognized over a weighted average period of 4.09 years. Any future change in estimated forfeitures will impact this amount. The total grant date fair value of stock options vested under our employee stock option plan during 2024, 2023, and 2022 was $7.6, $5.3, and $5.2, respectively. Total stock-based compensation expense related to our employee stock option plan was $8.0, $7.3, and $7.2 for 2024, 2023, and 2022, respectively. Shares Outstanding Shares of common stock outstanding were as follows: 2024 2023 2022 Balance at beginning of year 571,982,367 570,811,674 575,464,682 Stock options exercised 1,338,085 1,170,693 346,992 Purchases of common stock — — (5,000,000) Balance at end of year 573,320,452 571,982,367 570,811,674 Net Income Per Share The following tables present a reconciliation of the denominators used in the computation of basic and diluted net income per share and a summary of the options to purchase shares of common stock which were excluded from the diluted net income per share calculation because they were anti-dilutive: Reconciliation 2024 2023 2022 Basic weighted average shares outstanding 572,708,065 571,271,846 573,777,790 Weighted shares assumed upon exercise of stock options 1,574,146 1,736,762 1,845,324 Diluted weighted average shares outstanding 574,282,211 573,008,608 575,623,114 Summary of Anti-dilutive Options Excluded 2024 2023 2022 Options to purchase shares of common stock 913,296 1,568,460 1,335,898 Weighted average exercise prices of options $ 63.57 53.80 55.25 Any dilutive impact summarized above related to periods when the average market price of our stock exceeded the exercise price of the potentially dilutive stock options then outstanding. |